Thyroid carcinoma, version 2.2014.

Details

Serval ID
serval:BIB_1E68574CC5E2
Type
Article: article from journal or magazin.
Collection
Publications
Title
Thyroid carcinoma, version 2.2014.
Journal
Journal of the National Comprehensive Cancer Network
Author(s)
Tuttle R.M., Haddad R.I., Ball D.W., Byrd D., Dickson P., Duh Q.Y., Ehya H., Haymart M., Hoh C., Hunt J.P., Iagaru A., Kandeel F., Kopp P., Lamonica D.M., Lydiatt W.M., McCaffrey J., Moley J.F., Parks L., Raeburn C.D., Ridge J.A., Ringel M.D., Scheri R.P., Shah J.P., Sherman S.I., Sturgeon C., Waguespack S.G., Wang T.N., Wirth L.J., Hoffmann K.G., Hughes M.
ISSN
1540-1413 (Electronic)
ISSN-L
1540-1405
Publication state
Published
Issued date
12/2014
Peer-reviewed
Oui
Volume
12
Number
12
Pages
1671-80; quiz 1680
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
These NCCN Guidelines Insights focus on some of the major updates to the 2014 NCCN Guidelines for Thyroid Carcinoma. Kinase inhibitor therapy may be used to treat thyroid carcinoma that is symptomatic and/or progressive and not amenable to treatment with radioactive iodine. Sorafenib may be considered for select patients with metastatic differentiated thyroid carcinoma, whereas vandetanib or cabozantinib may be recommended for select patients with metastatic medullary thyroid carcinoma. Other kinase inhibitors may be considered for select patients with either type of thyroid carcinoma. A new section on "Principles of Kinase Inhibitor Therapy in Advanced Thyroid Cancer" was added to the NCCN Guidelines to assist with using these novel targeted agents.
Keywords
Adenocarcinoma/drug therapy, Adenocarcinoma/pathology, Anilides/therapeutic use, Carcinoma, Neuroendocrine, Guidelines as Topic, Humans, Neoplasm Metastasis, Niacinamide/analogs & derivatives, Niacinamide/therapeutic use, Phenylurea Compounds/therapeutic use, Protein Kinase Inhibitors/therapeutic use, Pyridines/therapeutic use, Sorafenib, Thyroid Neoplasms/drug therapy, Thyroid Neoplasms/pathology
Pubmed
Web of science
Open Access
Yes
Create date
27/12/2020 22:42
Last modification date
28/12/2020 6:26
Usage data